Evaluation of the antiretroviral activity of a new polyherbal drug (Immu-25) in patients with HIV infection

To evaluate the clinical efficacy and safety of a new polyherbal preparation, Immu-25, in HIV-infected patients. 36 patients (10 female, 26 male) with a mean age of 35 +/-10 years, with confirmed HIV infection with a CD4 count

Saved in:
Bibliographic Details
Published in:Drugs in R&D 2003, Vol.4 (2), p.103-109
Main Authors: Usha, P R, Naidu, M U R, Raju, Y S N
Format: Article
Language:English
Subjects:
Acquired Immunodeficiency Syndrome - drug therapy
Administration, Oral
Adult
Anti-HIV Agents - therapeutic use
CD4 Antigens - blood
CD8 Antigens - blood
HIV Infections - drug therapy
Human immunodeficiency virus
Humans
Middle Aged
Ocimum
Patients
Phytotherapy
Pilot Projects
Plant Extracts - adverse effects
Plant Extracts - pharmacology
Plant Extracts - therapeutic use
Time Factors
Tinospora
Treatment Outcome
Viral Load - methods
Withania
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To evaluate the clinical efficacy and safety of a new polyherbal preparation, Immu-25, in HIV-infected patients. 36 patients (10 female, 26 male) with a mean age of 35 +/-10 years, with confirmed HIV infection with a CD4 count
ISSN:1174-5886
DOI:10.2165/00126839-200304020-00003